Navigation Links
Pelosi Statement on the Death of Dr. Michael DeBakey
Date:7/12/2008

WASHINGTON, July 12 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi issued the following statement on the death of renowned heart surgeon Dr. Michael DeBakey:

"In his 70 years of medical practice, Dr. DeBakey had given hope and

health to patients and families across the globe by literally fixing

broken hearts. We honored his innovative spirit by awarding him the

Congressional Gold Medal earlier this year.

"Dr. DeBakey was one of our nation's preeminent medical pioneers whose

work and research saved millions of lives, including many on the

battlefield. He introduced MASH units, giving our soldiers not only

recovery and life, but the courage to continue to fight.

"We are all thankful for his everlasting contributions and honor his

lasting memory."


'/>"/>
SOURCE Office of the Speaker of the House
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Pelosi: SCHIP Bill a Giant Step for Americas Children
2. Pelosi Statement on Proposed Entitlement Task Force
3. Pelosi: Todays Sweeping, Bipartisan Legislation to Improve Drug Safety is a Victory for All Americans
4. Pelosi, Slaughter and Tubbs Jones Introduce Health Tracking Legislation
5. Pelosi: Mr. President - Drop the Partisan Rhetoric, Put Down the Veto Pen
6. Pelosi: Tonights Strong Bipartisan Vote for Childrens Health Insurance a Victory for Americas Children
7. Pelosi Statement on House Vote to Extend Family and Medical Leave for Military Families
8. Pelosi and Reid: Congress Sends President Bush Bipartisan Childrens Health Insurance Bill
9. Pelosi Statement on National Breast Cancer Awareness Month
10. Pelosi: We Remain Committed to Making SCHIP Into Law - With or Without the Presidents Support
11. Pelosi: This Week, Members Must Choose Between Partisan Obstruction and Health Insurance for 10 Million Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 2015 Elandas announces the creation of ... the company prepares to announce its next generation product ... in the Life Sciences field. , “Elandas depends on ... Elandas CEO Ryan Roberts. “We have been fortunate to ... our collaborative efforts. As we continue to grow, we ...
(Date:3/4/2015)... The emergence of nanotechnology has ... past decade. The pharmaceutical world has witnessed advancements ... the form of liposomes and polymeric nanoparticles that ... safety and efficiency. In the area of ... upon the enhanced permeability and retention (EPR) effect ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Ultraman Florida ... 6.2 mile swim, 261.4 mile bike, and 52.4 mile ... total time of 24:45:45. , "This race was awesome ... my wonderful team and sponsors for supporting me through ... Florida 2015 had a total of 40 select participants ...
(Date:3/4/2015)... March 04, 2015 TROY Healthcare Solutions ... which provides the ultimate level of security for prescriptions, ... Hilton Houston Plaza Medical Center located at 6633 Travis ... Beginning at 7 AM, TROY Healthcare Solutions will host ... Solutions will offer brief presentations each hour to introduce ...
(Date:3/4/2015)... NY (PRWEB) March 04, 2015 Smokers ... breakthrough marketing campaign called 'We Love Smokers' from Aqua-Tine, ... for tobacco. , "It’s important to establish a ... true to it. Our idea, 'We Love Smokers' elevates ... point of view. We created a bold tone of ...
Breaking Medicine News(10 mins):Health News:Elandas Creates Advisory Board to Help Guide Innovation 2Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 2Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 3Health News:Living Fuel Champion Christian Isakson Finishes Second In UltraMan Florida Test of Endurance 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 2Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 3
... RIO DE JANEIRO, Dec. 9 Amilpar (Bovespa: ... the largest managed,care organization in Brazil, in addition to the ... informs its shareholders and the,market that the initiatives to proceed ... Applicant its subsidiary AMIL ASSISTENCIA MEDICA,INTERNACIONAL LTDA. The filing to ...
... SANTA ROSA, Calif., Dec. 9 Kendall-Jackson Winery today ... for Cancer Research, concluding its five-month-long, online auction of ... from champion racehorse Rachel Alexandra,s historic 2009 racing season. ... The highest-earning single item was the final lot: a ...
... same as last year, survey shows , WEDNESDAY, Dec. 9 (HealthDay ... of the flu in general, there has been only a slight ... flu shot, a new report shows. , By the middle of ... is recommended had gotten a shot, according to the survey. Seasonal ...
... Dec. 9 The Michigan Minority Business Development Council ... On September 29 at the Detroit Symphony Orchestra/Max Fisher Music ... The theme for this year,s awards was: "Celebrating the ... corporations and individuals who actively include certified minority suppliers in ...
... , SOUTHFIELD, Mich., Dec. 9 Blue Care Network has announced ... be retiring at the end of February after a 33-year career ... Cross Blue Shield of Michigan. , The company will ... , "Jeanne has led the way for Blue Care Network ...
... , ... today announced a C$22.5 million project with the Government of ... of an electronic healthcare records (EHR) system. This technology can ... information, which can improve the efficiency and quality of patient ...
Cached Medicine News:Health News:Rachel Alexandra, Kendall-Jackson Donate $20,000 to V Foundation for Cancer Research 2Health News:Seasonal Flu Vaccination Rates Still Too Low 2Health News:Seasonal Flu Vaccination Rates Still Too Low 3Health News:Mike Lucas of GE Healthcare Recognized as the Lifeline for Minority Businesses; Receives the MMBDC 2009 President's Award 2Health News:Blue Care Network CEO Jeanne Carlson to Retire at the End of February 2010 2Health News:IBM Chosen to Build System for Electronic Health Records in Manitoba for Improved Patient Care 2Health News:IBM Chosen to Build System for Electronic Health Records in Manitoba for Improved Patient Care 3
(Date:3/4/2015)... 5. März 2015 Unfors ... im Bereich diagnostische Röntgenstrahlung, stellte heute ... dem European Congress of Radiology (ECR) ... Österreich, einen neuen Strahlungsüberwachungssensor vor. ... Der RaySafe X2-Überwachungssensor ...
(Date:3/4/2015)... Holdings, Inc. (NYSE: HRC ) announced today ... to its Board of Directors.  She most recently served ... as President of Covidien,s Vascular Therapies Division from 2012 to ... 2012. Ms. Enxing Seng joined Covidien in ... she was a founding member and executive officer responsible ...
(Date:3/4/2015)...  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... Phase II proof of concept clinical study investigating ... monotherapy in the treatment of chronic pruritus in ... and clinically meaningful improvement from baseline by tradipitant ... a 100mm unit Visual Analog Scale (VAS) for ...
Breaking Medicine Technology:Unfors RaySafe, ein Unternehmen von Fluke Biomedical, stellt auf European Congress of Radiology neuen Überwachungssensor vor 2Unfors RaySafe, ein Unternehmen von Fluke Biomedical, stellt auf European Congress of Radiology neuen Überwachungssensor vor 3Hill-Rom Elects Stacy Enxing Seng to its Board of Directors 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 3Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 4Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 5Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 6Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 7
... The microprocessor controlled, Blanketrol ... therapy system provides effective patient ... one system! The Blanketrol II ... highest flow rates of any ...
Inquire...
Inquire...
... and accurate immunoassay for the quantification of ... fully automated Elecsys proBNP assay helps to ... NT-proBNP levels also indicate the severity of ... prognosis. In addition, NT-proBNP facilitates monitoring, allowing ...
Medicine Products: